1834 Investment Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.5M Sell
101,154
-4,850
-5% -$433K 1.19% 20
2026
Q1
$7.61M Sell
106,004
-12,043
-10% -$928K 0.95% 30
2025
Q4
$9.37M Sell
118,047
-5,386
-4% -$425K 1.18% 20
2025
Q3
$9.31M Buy
123,433
+2,691
+2% +$184K 1.14% 21
2025
Q2
$8.33M Sell
120,742
-697
-0.6% -$45.7K 1.05% 25
2025
Q1
$8.23M Buy
121,439
+5,436
+5% +$325K 1.06% 26
2024
Q4
$5.21M Sell
116,003
-19,778
-15% -$1.11M 0.66% 45
2024
Q3
$8.54M Sell
135,781
-3,395
-2% -$198K 0.99% 27
2024
Q2
$8.22M Buy
139,176
+28,510
+26% +$1.78M 0.99% 24
2024
Q1
$8.83M Sell
110,666
-896
-0.8% -$68.4K 1.05% 22
2023
Q4
$8.81M Sell
111,562
-4,699
-4% -$334K 1.05% 23
2023
Q3
$8.12M Buy
116,261
+29,199
+34% +$2.07M 1.01% 26
2023
Q2
$6.02M Buy
87,062
+23,680
+37% +$1.68M 0.72% 37
2023
Q1
$4.71M Buy
63,382
+455
+0.7% +$38.2K 0.56% 53
2022
Q4
$5.86M Sell
62,927
-2,139
-3% -$206K 0.84% 37
2022
Q3
$6.21M Sell
65,066
-10,019
-13% -$992K 0.93% 38
2022
Q2
$6.96M Sell
75,085
-6,027
-7% -$588K 0.98% 37
2022
Q1
$8.21M Sell
81,112
-49,917
-38% -$5.24M 1.01% 37
2021
Q4
$13.5M Sell
131,029
-2,164
-2% -$200K 1.53% 16
2021
Q3
$11.3M Buy
133,193
+4,247
+3% +$356K 1.38% 18
2021
Q2
$10.8M Sell
128,946
-5,114
-4% -$419K 1.3% 23
2021
Q1
$10.1M Sell
134,060
-4,704
-3% -$343K 1.3% 24
2020
Q4
$9.48M Sell
138,764
-343
-0.2% -$22.3K 1.26% 28
2020
Q3
$8.12M Buy
139,107
+4,651
+3% +$289K 1.18% 30
2020
Q2
$8.74M Buy
134,456
+16,169
+14% +$1.02M 1.38% 20
2020
Q1
$7.02M Buy
118,287
+14,040
+13% +$937K 1.33% 22
2019
Q4
$7.75M Sell
104,247
-24,753
-19% -$1.74M 1.19% 31
2019
Q3
$8.14M Buy
129,000
+15,180
+13% +$900K 1.18% 30
2019
Q2
$6.2M Buy
113,820
+3,698
+3% +$199K 0.93% 39
2019
Q1
$5.94M Buy
110,122
+24,015
+28% +$1.48M 0.9% 44
2018
Q4
$5.64M Sell
86,107
-5,661
-6% -$423K 0.94% 44
2018
Q3
$7.22M Buy
91,768
+3,106
+4% +$222K 1.05% 38
2018
Q2
$5.71M Buy
88,662
+5,410
+6% +$357K 0.89% 48
2018
Q1
$5.18M Buy
83,252
+4,554
+6% +$327K 0.88% 41
2017
Q4
$5.71M Buy
78,698
+4,585
+6% +$333K 0.9% 40
2017
Q3
$6.03M Buy
74,113
+22,187
+43% +$1.76M 1.12% 32
2017
Q2
$4.18M Sell
51,926
-5,480
-10% -$433K 0.79% 52
2017
Q1
$4.51M Buy
57,406
+23,413
+69% +$1.87M 0.86% 45
2016
Q4
$2.68M Buy
+33,993
New +$2.75M 0.54% 54
2016
Q3
Sell
-54,319
Closed -$5.2M 168
2016
Q2
$5.2M Buy
54,319
+3,629
+7% +$362K 1.13% 33
2016
Q1
$5.26M Buy
50,690
+7,836
+18% +$762K 1.2% 29
2015
Q4
$4.19M Buy
+42,854
New +$4.2M 0.98% 36

Other funds holding CVS

1834 Investment Advisors's CVS Position: Q2 2026 in Review

1834 Investment Advisors reduced its CVS Health (CVS) stake by 4.6% in Q2 2026, selling an estimated $433K and leaving 101,154 shares worth $10.5M. The position accounts for 1.19% of the portfolio, ranked #20.

1834 Investment Advisors first reported a position in CVS in Q4 2015 and has held it in 42 quarters since. The position peaked at $13.5M in Q4 2021. 937 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • 1834 Investment Advisors held 101,154 shares of CVS Health worth $10.5M as of Q2 2026.
  • 1834 Investment Advisors sold 4,850 CVS Health shares in Q2 2026, an estimated $433K.
  • CVS Health made up 1.19% of 1834 Investment Advisors's portfolio in Q2 2026, its #20 holding.
  • 1834 Investment Advisors first reported a position in CVS Health in Q4 2015 and has held it in 42 quarters since.
  • 1834 Investment Advisors's CVS Health position peaked at $13.5M in Q4 2021.
  • 937 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on 1834 Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.